Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Maria Fernanda Guerra-Veloz"'
Publikováno v:
Medicine. 51:347-350
Autor:
Kosh Agarwal, Angelo Armandi, Genoveva Berná, George Boon-Bee Goh, Elisabetta Bugianesi, Esther W. Chan, Jacky C.H. Chan, Ka Wang Cheung, Won-Mook Choi, Jonggi Choi, Andrea Cornejo, Claire Crowley, Yock Young Dan, Delphine Degré, Pierre Deltenre, Oluwaseun Falade-Nwulia, Jian-Gao Fan, Yi Bin Feng, Peter Ferenci, Miguel Fernández Gómez, Malin Fromme, Lisbet Grønbæk, Henning Grønbæk, Mukesh Harisinghani, Giuseppe Indolfi, Takako Inoue, Jeong Won Jang, Guan Sen Kew, Kevin Kim-Jun Teh, Min Kim, Mikkel Breinholt Kjær, Linda Skibsted Kornerup, Carmen Lara Romero, Sung Won Lee, Soon Kyu Lee, Young-Suk Lim, Chieh Liu, Chun-Jen Liu, James Lok, Lucía López Bermudo, Lung-Yi Mak, Nahum Méndez-Sánchez, Christophe Moreno, Mark Muthiah, Heechul Nam, Yvonne A. Nartey, Pankaj Nepal, Mindie H. Nguyen, Emanuele Nicastro, Eiichi Ogawa, Jean-Michel Pawlotsky, Serena Pelusi, Jason Pik-Eu Chang, Mathias Plauth, Manuel Romero-Gómez, Luisa Ronzoni, Mimi Tin-Yan Seto, Yi-Wen Shi, Yi-Fen Shih, Siddharth Sridhar, Alexander J. Stockdale, Pavel Strnad, Yasuhito Tanaka, Rolf Teschke MD, Joseph D. Tucker, Luca Valenti, Maria Fernanda Guerra Veloz, Man-Fung Yuen, Cheng Zhang, Jiaxi Zhao, Kali Zhou
Publikováno v:
Comprehensive Guide to Hepatitis Advances ISBN: 9780323983686
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6ee6f27492efd159918648e734b08ae5
https://doi.org/10.1016/b978-0-323-98368-6.01002-8
https://doi.org/10.1016/b978-0-323-98368-6.01002-8
Publikováno v:
Comprehensive Guide to Hepatitis Advances ISBN: 9780323983686
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eb0c38fde21da17cc68b5d9a2f65b475
https://doi.org/10.1016/b978-0-323-98368-6.00017-3
https://doi.org/10.1016/b978-0-323-98368-6.00017-3
Autor:
Manuel Romero-Gómez, Maria Fernanda Guerra-Veloz, José Miguel Rosales, Marta Casado, Angeles Lopez-Garrido, Francisca Sousa, Ana Aparicio, Matias Estevez, M. Maraver, Javier Ampuero, Isabel Carmona, Banca Figueruela, Juan Manuel Pascasio, Raúl J. Andrade
[Introduction] Despite the direct-acting antiviral therapy has dramatically decreased the likelihood of having liver-related complications and extrahepatic outcomes, the risk of developing hepatocellular carcinoma (HCC) is not totally eliminated afte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc224f2ac9cb421eeefcce84a481349d
http://hdl.handle.net/10261/288050
http://hdl.handle.net/10261/288050
Autor:
Saima Ajaz, Mark Chamley, James Lok, Riham Soliman, Reece Khan, Karan Ahir, Monique Curtis, María Fernanda Guerra-Veloz, Kosh Agarwal
Publikováno v:
Therapeutic Advances in Chronic Disease, Vol 15 (2024)
Background: Metabolic associated fatty liver disease (MAFLD) stands as the leading cause of chronic liver disease globally. Notably, individuals with metabolic risk factors, such as diabetes and obesity, exhibit a staggering prevalence of MAFLD, with
Externí odkaz:
https://doaj.org/article/d6c2f9248dfc42f487abcf929983a9b6
Autor:
Paula Fernández-Alvarez, María Fernanda Guerra-Veloz, Angel Vilches-Arenas, Patricia Cordero-Ruíz, Francisco Bellido-Muñoz, Angel Caunedo-Alvarez, Isabel Carmona-Soria
Publikováno v:
Viruses, Vol 15, Iss 6, p 1251 (2023)
Objectives: The course of progressive liver damage after achieving sustained virological response (SVR) with direct-acting antivirals (DAAs) remains undetermined. We aimed to determine risk factors associated with the development of liver-related eve
Externí odkaz:
https://doaj.org/article/2377b7418abf4291867b4557775418c4
Autor:
Heiner Wedemeyer, Vito Di Marco, Montserrat Garcia-Retortillo, Elisabetta Teti, Chris Fraser, Luis Enrique Morano Amado, Sergio Rodriguez-Tajes, Silvia Acosta-López, Joss O’Loan, Michele Milella, Maria Buti, María Fernanda Guerra-Veloz, Alnoor Ramji, Mary Fenech, Alexandra Martins, Sergio M. Borgia, Kim Vanstraelen, Michael Mertens, Cándido Hernández, Ioanna Ntalla, Heribert Ramroth, Scott Milligan
Publikováno v:
Viruses, Vol 14, Iss 11, p 2493 (2022)
Hepatitis C virus (HCV) is prevalent in people with mental health disorders, a priority population to diagnose and cure in order to achieve HCV elimination. This integrated analysis pooled data from 20 cohorts in seven countries to evaluate the real-
Externí odkaz:
https://doaj.org/article/9f2d4475c8694efd9435ba7e89f6c329
Publikováno v:
JHEP Reports, Vol 6, Iss 11, Pp 101093- (2024)
Externí odkaz:
https://doaj.org/article/0306a9a908094ca1849a5641c47fd8c5
Autor:
Dina Chaaro-Benallal, María Fernanda Guerra-Veloz, Federico Argüelles-Arias, José Manuel Benítez, Raúl Perea-Amarillo, Eva Iglesias, Luisa Castro-Laria, Valle Sánchez-García, Belén Maldonado-Pérez, Ángel Vilches, Ángel Caunedo-Álvarez, Manuel Romero-Gómez
Publikováno v:
Revista Espanola de Enfermedades Digestivas, Vol 109, Iss 11, Pp 757-760
Background: The incidence of inflammatory bowel disease is increasing in Europe and in Spain. However, there is no recent data from Southern Spain. Objectives: To determine the evolution of the hospital incidence of inflammatory bowel disease in Sout
Externí odkaz:
https://doaj.org/article/abcafda471274352bbd85229105a4b05
Autor:
Maria-Fernanda Guerra-Veloz, Juan-María Vázquez-Morón, María Belvis-Jiménez, Héctor Pallarés-Manrique, Teresa Valdés-Delgado, Luisa Castro-Laria, Belén Maldonado-Pérez, Antonio Benítez-Roldán, Raúl Perea-Amarillo, Vicente Merino, Ángel Caunedo-Álvarez, Ángel Vilches-Arenas, Federico Argüelles-Arias
Publikováno v:
Revista Espanola de Enfermedades Digestivas, Vol 110, Iss 9, Pp 564-570 (2018)
ABSTRACT Background and aims: infliximab has changed the natural history of inflammatory bowel disease (IBD). The advent of biosimilar treatments such as CT-P13 will hopefully improve the availability of biological therapies. Data with regard to dru
Externí odkaz:
https://doaj.org/article/0e6345d5ab5d4913be382ed841c819f6